Feature | ACC | March 19, 2019

ACC 2019 Late-breaking Presentations

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 annual meeting March 16-18, 2019, in New Orleans. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.

ACC also announced the new ACC/AHA 2019 Guideline on the Primary Prevention of Cardiovascular Disease will be released at ACC.19. This guideline will focus on primary prevention of cardiovascular disease in adults and present recommendations to prevent CVD related to lifestyle factors as well as other factors affecting cardiovascular risk.

For more information on the ACC.19 annual meeting, visit https://accscientificsession.acc.org.

 

Saturday, March 16
Joint ACC and Journal of the ACC Late-Breaking Clinical Trials I

The Apple Heart Study: Results Of A Large-scale, App-based Study To Identify Atrial Fibrillation Using A Smartwatch

 

Saturday, March 16
Featured Clinical Research I

 

Sunday, March 17
Joint ACC/New England Journal of Medicine Late-Breaking Clinical Trials II

 

Sunday, March 17
Joint ACC/Journal of the American Medical Association Late-Breaking Clinical Trials III

 

Sunday, March 17
Featured Clinical Research II: Interventional

  

Monday, March 18
Late-Breaking Clinical Trials IV

 

Monday, March 18
Late-Breaking Clinical Trials V

 

Monday, March 18
Featured Clinical Research III

 

Other ACC.19 News and Video:

VIDEO: Utilization of PET For Evaluation of Cardiac Sarcoidosis — Interview with Raza Alvi, M.D.,

VIDEO: Key Trends in Electrophysiology — Apple Watch to Detect AF and the CABANA Trial — Interview with Christine Albert, M.D.

 

Related ACC 2019 Content:

 

Links to ACC 2019 Late-breaking Presentations

VIDEO: Use of an Antibacterial Envelope to Reduce Infections for Pacemakers, ICDs — Interview with Khaldoun Tarakji, M.D.

PODCAST: Fitting Artificial Intelligence Into Cardiology — Interview with Anthony Chang, M.D.

Sunday ACC 2019: Mixed Reality Offers Advantages of Virtual and Augmented Realities

VIDEO: Key Trends in Electrophysiology — Apple Watch to Detect AF and the CABANA Trial — Interview with Christine Albert, M.D.

Video Game Format Used to Train Cardiologists

PODCAST: How Technology Is Changing Cardiology — Interview with Partho P. Sengupta, M.D., 

VIDEO: Why Are There So Many Foreign Doctors? — Interview with William Pinsky, M.D., and Mandeep Mehra, M.D., 

PODCAST: Shortcomings of CTA in Cardiology — Interview with Todd C. Villines, M.D.

VIDEO: Use of Wearables to Track Electrophysiology Patients — Interview with Khaldoun Tarakji, M.D.

Saturday ACC 2019: How Machine Learning Empowers Echo Users Today

ACC.19 Future Hub Hosts “Shark Tank” of Emerging Technologies In Cardiology

VIDEO: Characterization of Cardiac Structural Changes and Function Following Radiation Therapy — Interview with Magid Awadalla, MBBS

PODCAST: Choosing CTA Over Functional Requires Judgment Call — Interview with Rami Doukky, M.D.

VIDEO: Utilization of PET For Evaluation of Cardiac Sarcoidosis — Interview with Raza Alvi, M.D.

HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year

 

Monday ACC 2019: How Interventionalists Can Keep From Missing Coronary Stenoses

 

Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT 

 

 

 

Links to Other Recent Late-breaking Trials: 

ACC 2018 Late-Breaking Trials

American Heart Association 2018 Late-breaking Trials

TCT 2018 Late-breaking Cardiovascular Clinical Trials

EuroPCR 2018 Late-breaking Trials in Interventional Cardiology

Heart Rhythm 2018 Late-breaking Studies

SCAI 2018 Late-breaking Clinical Trials

Related Content

American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Overlay Init